Literature DB >> 976811

Hypergastrinaemia in cirrhosis of liver.

S K Lam.   

Abstract

The basal acid output (BAO), post-pentagastrin acid output (MAO), fasting and post-prandial gastrin levels in 40 patients with proven cirrhosis of the liver were compared with those in 20 normal controls. The mean BAO and MAO were significantly lower than normal, the mean fasting gastrin level was significantly higher than normal, and the postprandial gastrin response was significantly increased and prolonged. These differences were still significant even when the patients were divided into cryptogenic and alcoholic subgroups. A significant inverse relationship between MAO and the integrated gastrin response to meal was observed both in the normal controls and in the cirrhotic patients. The MAO and integrated gastrin response of the cirrhotic patients did not correlate with the degree of liver function impairment. In five cirrhotic patients fasting and postprandial gastrin levels were unchanged after splenorenal shunt operation. A more consistent abnormality of the gastric mucosa as assessed by endoscopy and biopsies appeared to be mucosal congestion with occasional atrophic gastritis. the severity of mucosal abnormality, however, was unrelated to the degree of hypoacidity. these results indicate, firstly, that the hypergastrinaemia in cirrhotic patients is a reflection of gastric hypoacidity and bears no direct relationship to hepatic dysfunction. Secondly, the gastric hypoacidity does not accrue solely from mucosal abnormality. It is suggested that this hypoacidity may result from the presence of excessive amounts of circulating acid-inhibiting intestinal peptides, which the diseased liver fails to metabolise.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976811      PMCID: PMC1411275          DOI: 10.1136/gut.17.9.700

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  REDUCED GASTRIC ACID OUTPUT IN CIRRHOSIS: QUANTITATION AND RELATIONSHIPS.

Authors:  B A SCOBIE; W H SUMMERSKILL
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

2.  PEPTIC ULCER AND GASTRIC SECRETION IN PATIENTS WITH LIVER DISEASE.

Authors:  S TABAQCHALI; A M DAWSON
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

3.  THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA.

Authors:  R A GREGORY; H J TRACY
Journal:  Gut       Date:  1964-04       Impact factor: 23.059

4.  Splenectomy in cryptogenetic splenomegaly.

Authors:  J COOK; A J McFADZEAN; D TODD
Journal:  Br Med J       Date:  1963-08-10

5.  Follow-up studies on an unselected ten-year material of 360 patients with liver cirrhosis in one community.

Authors:  J HALLEN; H KROOK
Journal:  Acta Med Scand       Date:  1963-04

6.  Gastric secretion in human hepatic cirrhosis.

Authors:  J D OSTROW; R J TIMMERMAN; S J GRAY
Journal:  Gastroenterology       Date:  1960-03       Impact factor: 22.682

7.  Sources of upper alimentary tract hemorrhage in cirrhosis of the liver.

Authors:  D C FAINER; J A HALSTED
Journal:  J Am Med Assoc       Date:  1955-01-29

8.  The neurological disorder associated with liver disease.

Authors:  R D ADAMS; J M FOLEY
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1953

9.  Massive hemorrhage in patients with both esophageal varices and duodenal ulcer.

Authors:  B H SULLIVAN; W F LIENHARD; J M LUKEMAN
Journal:  Gastroenterology       Date:  1954-06       Impact factor: 22.682

10.  The association of peptic ulcer with cirrhosis of the liver. An analysis of an autopsy series.

Authors:  F Bergman; W van der Linden
Journal:  Acta Pathol Microbiol Scand       Date:  1965
View more
  12 in total

1.  Gastric red spots in patients with cirrhosis: subclinical condition of gastric mucosal hemorrhage?

Authors:  T Iwao; A Toyonaga; K Tanikawa
Journal:  Gastroenterol Jpn       Date:  1990-12

2.  Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone.

Authors:  T Iwao; A Toyonaga; M Ikegami; H Shigemori; K Oho; M Sumino; K Tanikawa
Journal:  Dig Dis Sci       Date:  1996-09       Impact factor: 3.199

3.  Plasma levels and renal removal of gastrin after acute hepatic ischemia in dogs.

Authors:  A Pezzarossa; S Contini; C Scarpignato; M Bairamian; V Coiro; U Butturini
Journal:  J Endocrinol Invest       Date:  1984-06       Impact factor: 4.256

4.  Gastric secretion and basal gastrin concentration in bilharzial hepatic fibrosis.

Authors:  P B Boulos; E T Okosdonossian; H A Elmunshid; S H Elmasri; M A Hassan; M Hobsley
Journal:  Gut       Date:  1978-09       Impact factor: 23.059

5.  Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively.

Authors:  M Rabinovitz; Y K Yoo; R R Schade; V J Dindzans; D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

6.  Mucosal lesions of the stomach in liver cirrhosis with a special reference to phospholipid metabolism.

Authors:  Y Hosokawa
Journal:  Gastroenterol Jpn       Date:  1991-06

7.  Renal control of the peripheral uptake of exogenous gastrin in the dog.

Authors:  J Loly; J C Depresseux; A Brassinne; A Nizet
Journal:  Pflugers Arch       Date:  1982-11-11       Impact factor: 3.657

Review 8.  Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis.

Authors:  J W Freston; K Borch; S J Brand; E Carlsson; W Creutzfeldt; R Håkanson; L Olbe; E Solcia; J H Walsh; M M Wolfe
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 9.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

10.  Prevalence of duodenal ulcer in cirrhotic males referred for liver transplantation. Does the etiology of cirrhosis make a difference?

Authors:  M Rabinovitz; R R Schade; V Dindzans; D H Van Thiel; J S Gavaler
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.